Role of lipegfilgrastim in the management of chemotherapy-induced neutropenia
Jonathan Hoggatt,1 Tiffany A Tate,1 Louis M Pelus2 1Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA, USA; 2Department of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, IN, USA Abstract: Chemotherapy, irradiation, and other age...
Saved in:
Main Authors: | Hoggatt J, Tate TA, Pelus LM |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2015
|
Subjects: | |
Online Access: | https://doaj.org/article/d1e3f98579804b9c81d3d3eb9b386d6e |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Role of lipegfilgrastim in the management of chemotherapy-induced neutropenia [Corrigendum]
by: Hoggatt J, et al.
Published: (2015) -
Lipegfilgrastim in the management of chemotherapy-induced neutropenia of cancer patients
by: Guariglia R, et al.
Published: (2016) -
Review on lipegfilgrastim
by: Gasparic M, et al.
Published: (2015) -
Biosimilars in the management of neutropenia: focus on filgrastim
by: Caselli D, et al.
Published: (2016) -
Lamotrigine‐induced neutropenia after high‐dose concomitant initiation with phenytoin
by: Muhammad Salem, et al.
Published: (2021)